Barrington Research Weighs in on Stericycle, Inc.’s Q3 2022 Earnings (NASDAQ:SRCL)

Stericycle, Inc. (NASDAQ:SRCLGet Rating) – Equities researchers at Barrington Research issued their Q3 2022 earnings estimates for shares of Stericycle in a research note issued to investors on Tuesday, April 19th. Barrington Research analyst K. Steinke anticipates that the business services provider will post earnings per share of $0.49 for the quarter. Barrington Research currently has a “Market Perform” rating on the stock. Barrington Research also issued estimates for Stericycle’s FY2023 earnings at $2.46 EPS.

Other analysts also recently issued research reports about the company. Robert W. Baird reduced their price objective on Stericycle from $77.00 to $72.00 and set an “outperform” rating for the company in a research report on Friday, February 25th. downgraded Stericycle from a “buy” rating to a “hold” rating in a research report on Thursday. Finally, Zacks Investment Research downgraded Stericycle from a “hold” rating to a “sell” rating and set a $62.00 target price for the company. in a research report on Tuesday, March 1st. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat, Stericycle has a consensus rating of “Hold” and an average price target of $67.00.

Shares of NASDAQ:SRCL opened at $55.56 on Friday. The business has a 50 day moving average price of $57.27 and a 200 day moving average price of $59.88. Stericycle has a twelve month low of $53.25 and a twelve month high of $79.97. The company has a market cap of $5.12 billion, a price-to-earnings ratio of -179.22, a PEG ratio of 3.16 and a beta of 1.30. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.66.

Stericycle (NASDAQ:SRCLGet Rating) last announced its earnings results on Thursday, February 24th. The business services provider reported $0.38 earnings per share for the quarter, missing the consensus estimate of $0.44 by ($0.06). Stericycle had a negative net margin of 1.05% and a positive return on equity of 8.26%. The business had revenue of $657.30 million for the quarter, compared to the consensus estimate of $662.25 million. During the same quarter in the previous year, the company earned $0.59 EPS. Stericycle’s revenue for the quarter was up .2% compared to the same quarter last year.

Hedge funds have recently added to or reduced their stakes in the stock. Whittier Trust Co. of Nevada Inc. acquired a new stake in Stericycle during the 3rd quarter valued at $31,000. Quent Capital LLC acquired a new stake in Stericycle during the 4th quarter valued at $33,000. First Horizon Advisors Inc. increased its holdings in Stericycle by 1,369.2% during the 3rd quarter. First Horizon Advisors Inc. now owns 573 shares of the business services provider’s stock valued at $43,000 after purchasing an additional 534 shares in the last quarter. Covestor Ltd acquired a new stake in Stericycle during the 4th quarter valued at $43,000. Finally, CastleArk Alternatives LLC acquired a new stake in Stericycle during the 3rd quarter valued at $52,000. 97.67% of the stock is owned by hedge funds and other institutional investors.

Stericycle Company Profile (Get Rating)

Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including sharps disposable and management solutions; pharmaceutical waste services; hazardous waste disposal; maritime waste services, such as seaport and airport waste; and compliance programs under the Steri-Safe, Clinical Services, First Practice Management, SeguriMed, and EnviroAssure brand names.

Featured Articles

Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with's FREE daily email newsletter.